Fertility potential in thalassemia major women: Current findings and future diagnostic tools

Annals of the New York Academy of Sciences

Volumn 1202, Issue , 2010, Pages 226-230

  Singer, Sylvia T ^a   Sweeters, Nancy ^b   Vega, Olivia ^b   Higa, Annie ^b   Vichinsky, Elliott ^a   Cedars, Marcelle ^c  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

fertility in thalassemia women; ovarian reserve testing (ORT); thalassemia major women

Indexed keywords

ESTRADIOL; FOLLITROPIN; FREE RADICAL; INHIBIN A; INHIBIN B; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR;

ADOLESCENT; ADULT; AGE; AGED; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONFERENCE PAPER; CORRELATION ANALYSIS; FEMALE; FEMALE FERTILITY; FERTILIZATION IN VITRO; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS; HYPOTHALAMUS; IRON CHELATION; IRON OVERLOAD; LIVER IRON CONCENTRATION; OVARIAN RESERVE; OXIDATIVE STRESS; PRIMARY AMENORRHEA; SECONDARY AMENORRHEA; SEXUAL DEVELOPMENT; THALASSEMIA MAJOR; TISSUE INJURY;

EID: 77955876121     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05583.x     Document Type: Conference Paper

References (30)

1. Borgna-Pignatti, C. et al. 2004. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89: 1187-1193.
2. Al-Rimawi, H.S. et al. 2005. Hypothalamic-pituitarygonadal function in adolescent females with betathalassemia major. Int. J. Gynaecol. Obstet . 90: 44-47.
3. Coccia, M.E. & F. Rizzello. 2008. Ovarian reserve. Ann. N.Y. Acad. Sci. 1127: 27-30.
4. Christoforidis, A. et al. 2007. MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major. Eur. J. Radiol. 62: 138-142.
5. Lutchman Singh, K.,M.Davies&R. Chatterjee. 2005. Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing. Hum. Reprod.Update. 11: 69-89.
6. Bronspiegel-Weintrob, N. et al. 1990. Effect of age at the start of iron chelation therapy on gonadal function in betathalassemia major.N. Engl. J. Med. 323: 713-719.
7. Allegra, A. et al. 1990. Hypogonadism in beta-thalassemic adolescents: a characteristic pituitary-gonadal impairment. The ineffectiveness of long-termiron chelation therapy. Gynecol. Endocrinol. 4: 181-191.
8. Agarwal, A., S.Gupta&R.K. Sharma. 2005. Role of oxidative stress in female reproduction. Reprod. Biol. Endocrinol. 3: 1-21.
9. Agarwal, A., S. Gupta & R. Sharma. 2005. Oxidative stress and its implications in female infertility-a clinician's perspective. Reprod. Biomed. Online 11: 641-650.
10. Tatone, C. et al. 2008. Cellular and molecular aspects of ovarian follicle ageing. Hum. Reprod. Update 14: 131-142.
11. Tarin, J.J. 1996. Potential effects of age-associated oxidative stress on mammalian oocytes/embryos. Mol. Hum. Reprod. 2: 717-724.
12. Livrea,M.A. et al. 1996. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 88: 3608-3614.
13. Perera, D. et al. 2002. SpermDNA damage in potentially fertile homozygous beta-thalassaemia patients with iron overload. Hum. Reprod. 17: 1820-1825.
14. De Sanctis, V. et al. 2008. Spermatozoal DNA damage in patientswith B thalassaemia syndromes. Pediatr. Endocrinol. Rev. 6(Suppl 1): 185-189.
15. DeSanctis,V. et al. 2008. Spermatogenesis in young adult patients with beta-thalassaemia major long-term treated with desferrioxamine. Georgian Med. News 156: 74-77.
16. Reubinoff, B.E. et al. 1996. Increased levels of redox-active iron in follicular fluid: a possible cause of free radicalmediated infertility in beta-thalassemiamajor. Am. J.Obstet. Gynecol. 174: 914-918.
17. Skordis, N. et al. 2004. Update on fertility in thalassaemia major. Pediatr. Endocrinol. Rev. 2(Suppl 2): 296-302.
18. Tuck, S.M. 2005. Fertility and pregnancy in thalassemiamajor. Ann. N.Y. Acad. Sci. 1054: 300-307.
19. Ansari, S., A. Azarkeivan & A. Tabaroki. 2006. Pregnancy in patients treated for beta thalassemia major in two centers (Ali Asghar Children's Hospital and Thalassemia Clinic): outcomefor mothers andnewborninfants. Pediatr.Hematol. Oncol. 23: 33-37.
20. Cunningham, M.J. et al. 2004. Complications of betathalassemia major in North America. Blood 104: 34-39.
21. Bajoria, R. & R. Chatterjee. 2009. Current perspectives of fertility and pregnancy in thalassemia. Hemoglobin 33(Suppl 1): S131-S135.
22. Sowers, M.R. et al. 2008. Anti-Mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J. Clin. Endocrinol. Metab. 93: 3478-3483.
23. Pavlik, E.J. et al. 2000. Ovarian volume related to age. Gynecol. Oncol. 77: 410-412.
24. van Rooij, I.A. et al. 2005. Serum anti-Mullerian hormone levelsbest reflect the reproductivedeclinewithage innormal women with proven fertility: a longitudinal study. Fertil. Steril. 83: 979-987.
25. Knauff, E.A. et al. 2009. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J. Clin. Endocrinol. Metab. 94: 786-792.
26. Broekmans, F.J. et al. 2008. Anti-Mullerian hormone and ovarian dysfunction. Trends Endocrinol.Metab. 19: 340-347.
27. Papadimas, J. et al. 2002.-thalassemia and gonadal axis: a cross-sectional, clinical study in a Greek population. Hormones (Athens) 1: 179-187.
28. Genazzani, A.D. et al. 1993. FSH secretory pattern and degree of concordance with LH in amenorrheic, fertile, and postmenopausal women. Am. J. Physiol. 264: E776-E781.
29. Argyropoulou, M.I., D.N. Kiortsis & S.C. Efremidis. 2003. MRIof the liver and the pituitary gland in patientswith betathalassemia major: does hepatic siderosis predict pituitary iron deposition? Eur. Radiol. 13: 12-16.
30. Miao, Y.L. et al. 2009. Oocyte aging: cellular and molecular changes, developmental potential and reversal possibility. Hum. Reprod. Update. 15: 573-585.